In response to COVID-19 pandemic, ProSci Inc has developed and manufactured COVID-19 antibodies, antigen reagents and recombinant proteins against the virus, and virus receptor ACE2. Our polyclonal, monoclonal, and recombinant single domain antibodies are available for order against COVID-19 virus SARS-CoV-2 spike, envelope, and nucleocapsid protein. Trial size antibodies as well as large quantities are available. https://www.prosci-inc.com/covid-19/